Skip to main content

Table 7 TUNA vs. other Minimally Invasive Therapies: adverse effects

From: Systematic review and meta-analysis of Transurethral Needle Ablation in symptomatic Benign Prostatic Hyperplasia

 

TUNA

TUMT

ILC

TUVP

VLAP

HIFU

WIT

Erectile dysfunction

7 (20%)

6 (26%)

7 (18%)

--

--

--

--

Epidydimitis

0 (0%)

--

--

0 (0%)

--

--

--

Urethral stenosis

--

--

--

2 (15%)

--

--

--

Retrograde ejaculation

9 (14%)

--

16(15%)

12 (92%)

--

--

--

Fever

--

--

1(1.4%)

1 (7.7%)

--

--

--

Transitory incontinence

--

--

--

2 (15%)

--

--

--

Urinary infection

--

--

--

2 (15%)

--

--

--

Urinary retention

--

--

--

1 (5.9%)

--

--

3 (24%)

Rehospitalization

1 (6.7%)

--

--

1 (5.9%)

1 (7%)

1 (5%)

4 (30.7%)

Irritative symptoms

--

--

30 (42%)

--

--

--

--

Reduction in seminal volume

--

--

15 (21%)

--

--

--

--

Hematuria

1 (6.8%)

--

25 (35.2%)

2 (11.8%)

0 (0%)

1 (5%)

--

Dysuria

2 (8.3%)

--

--

--

--

--

--

Change in sexual activity

0 (0%)

--

--

--

--

--

--

  1. Results are expressed as number of cases and percentages. Abbreviations. TUMT: Transurethral Microwave Thermotherapy. WIT: Water-induced Thermotherapy. ILC: Interstitial laser coagulation TUVP: Transurethral Electrovaporization of the prostate. VLAP: Visual Laser Ablation of the prostate. HIFU: Transrectal High Intensity Focused Ultrasound.